Most Clicked StoriesMore >


Aspirin effective against venous thromboembolism

AABB SmartBrief | May 24, 2012

Aspirin can serve as an alternative to treatment with the anticoagulant warfarin for the prevention of venous thromboembolism after a standard course of anticoagulant therapy, according to an Italian study published in the New England Journal of Medicine. Aspirin "may reduce recurrence of venous thromboembolism without increasing complications," according to the lead researcher. U.S. News & World Report (05/23)


Doctors remove foot-long blood clot without open-heart surgery

AABB SmartBrief | May 23, 2012

Bioreactor allows stem cell production by the billion

AABB SmartBrief | May 25, 2012

ITxM, PSBC reach preliminary agreements with Creative Testing Solutions

AABB SmartBrief | May 24, 2012

EU calls for stronger advice on bleeding risk of anticoagulant

AABB SmartBrief | May 29, 2012

10 recommendations aim for more transparent clinical trial reports

AABB SmartBrief | May 23, 2012

Australian Red Cross to study accuracy of blood donor information

AABB SmartBrief | May 24, 2012

Portable imaging device captures blood cells flowing inside body

AABB SmartBrief | May 23, 2012

Researchers develop needle-free injection system

AABB SmartBrief | May 24, 2012

Doctors develop stem cell treatment for patients with hip damage

AABB SmartBrief | May 29, 2012


Find AABB SmartBrief Issues by Date:



AABB News More >


Free audioconference to highlight benefits of participation in AABB's patient safety organization

AABB SmartBrief | May 29, 2012

Reminder: Candidates announced for open positions on 2012-13 AABB Board of Directors

AABB SmartBrief | May 25, 2012

Reminder: AABB publishes new patient blood management resource

AABB SmartBrief | May 24, 2012

Reminder: Join AABB's Transfusion Safety Group within CDC's NHSN Hemovigilance Module

AABB SmartBrief | May 23, 2012

Reminder: Deadline approaching for eligible individuals and organizations to buy tickets for NBF raffle; winner will receive 3-year lease on bloodmobile

AABB SmartBrief | May 22, 2012




Sign up for AABB SmartBrief



Designed specifically for the transfusion medicine and cellular therapy community, AABB SmartBrief is a FREE, daily e-mail newsletter. It provides a summary of the most important news in our field to members of AABB and beyond. To save time and stay smart, sign up today to receive AABB SmartBrief, free of charge. Learn more